1. Home
  2. CYTK vs COMP Comparison

CYTK vs COMP Comparison

Compare CYTK & COMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • COMP
  • Stock Information
  • Founded
  • CYTK 1997
  • COMP 2012
  • Country
  • CYTK United States
  • COMP United States
  • Employees
  • CYTK N/A
  • COMP N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • COMP EDP Services
  • Sector
  • CYTK Health Care
  • COMP Technology
  • Exchange
  • CYTK Nasdaq
  • COMP Nasdaq
  • Market Cap
  • CYTK 4.6B
  • COMP 4.2B
  • IPO Year
  • CYTK 2004
  • COMP 2021
  • Fundamental
  • Price
  • CYTK $59.89
  • COMP $7.41
  • Analyst Decision
  • CYTK Buy
  • COMP Buy
  • Analyst Count
  • CYTK 16
  • COMP 8
  • Target Price
  • CYTK $76.73
  • COMP $9.75
  • AVG Volume (30 Days)
  • CYTK 2.5M
  • COMP 13.6M
  • Earning Date
  • CYTK 11-05-2025
  • COMP 10-29-2025
  • Dividend Yield
  • CYTK N/A
  • COMP N/A
  • EPS Growth
  • CYTK N/A
  • COMP N/A
  • EPS
  • CYTK N/A
  • COMP N/A
  • Revenue
  • CYTK $85,738,000.00
  • COMP $6,290,200,000.00
  • Revenue This Year
  • CYTK $363.61
  • COMP $24.26
  • Revenue Next Year
  • CYTK $64.08
  • COMP $12.79
  • P/E Ratio
  • CYTK N/A
  • COMP N/A
  • Revenue Growth
  • CYTK 2635.74
  • COMP 21.23
  • 52 Week Low
  • CYTK $29.31
  • COMP $5.10
  • 52 Week High
  • CYTK $61.19
  • COMP $10.25
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 75.04
  • COMP 36.80
  • Support Level
  • CYTK $47.22
  • COMP $7.37
  • Resistance Level
  • CYTK $50.78
  • COMP $8.00
  • Average True Range (ATR)
  • CYTK 2.30
  • COMP 0.41
  • MACD
  • CYTK 0.66
  • COMP -0.14
  • Stochastic Oscillator
  • CYTK 90.55
  • COMP 6.79

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

Share on Social Networks: